Advertisement
Supported by
Duodenoscopes have sickened hundreds of patients in hospital outbreaks. Now some experts are demanding the devices be redesigned or taken off the market.
By
There may be as many explanations as there are killers. But over the decades, scientists have seen some patterns emerge.
By
Problems with disposal of dangerous materials led the government to suspend research at the military’s leading biodefense center.
By
As lawyers for cities and counties push a plan for a nationwide settlement of opioid lawsuits, states push back, saying they should lead the way.
By
Drug-resistant infections from food are growing. But powerful industry interests are blocking scientists and investigators from getting information they need to combat the problem.
By
Too often, people with incurable cancers pursue therapy beyond any hope of benefit — except, perhaps, to the pockets of Big Pharma.
By
A whistle-blower said the leading charity favored patients from the major dialysis chains because the companies were its biggest donors.
By Reed Abelson and
One expert warns of “unintended downsides,” including overuse of only modestly effective medications.
By
There is a question about what role race and wealth play in how much attention and funding the disease receives.
By
Advertisement
A pig kidnapping highlights the concerns over antibiotics in livestock.
By Travis Dove and
Overuse of antibiotics in livestock has given rise to drug-resistant germs. Drugmakers say they want to be part of the solution. But a recent campaign urged farmers to administer the drugs to healthy animals daily.
By Danny Hakim and
The state health department calls on hospitals to do more to fight Candida auris, a mystery germ spreading the globe.
By
In its decision to approve two drugs for orange and grapefruit trees, the E.P.A. largely ignored objections from the C.D.C. and the F.D.A., which fear that expanding their use in cash crops could fuel antibiotic resistance in humans.
By Andrew Jacobs and
A new report says the overuse of antimicrobial drugs in humans, animals and plants is fueling resistant pathogens that could kill 10 million people annually by 2050.
By
Advertisement
Advertisement
